로딩 중…
지수 로딩 중…
인바이오
352940· KOSDAQ· Materials· Materials
₩1,967+2.45%
2026-11-02
Financials
Valuation Metrics
인바이오's Market Cap is ₩214B. At end of 2025 it was ₩247B. Ranked #2226 of 2,405 in KR market (top 93%), #1466 of 1,627 on KOSDAQ (top 90%), #271 of 292 in Materials (top 93%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 21.38B KRW | KR#2,226/2,405 Sec#271/292 |
| Revenue | 36.18B KRW | KR#1,954/2,405 Sec#268/292 |
| Net Income | 574.5M KRW | KR#1,513/2,405 Sec#200/292 |
| Total Assets | 78.88B KRW | KR#1,937/2,405 Sec#261/292 |
| Net Assets | 44.52B KRW | KR#1,976/2,405 Sec#260/292 |
| Employees | 147 | KR#1,339/2,405 Sec#166/292 |
| Value | ||
| P/E | 37.21x | KR#1,371/2,405 Sec#183/292 |
| P/B | 0.48x | KR#824/2,405 Sec#160/292 |
| PEG | 0.12x | KR#472/2,405 Sec#58/292 |
| P/S | 0.59x | KR#1,085/2,405 Sec#186/292 |
| EV/EBITDA | 34.62x | KR#1,264/2,405 Sec#169/292 |
| FCF Yield | 10.60% | KR#618/2,405 Sec#71/292 |
| Profitability | ||
| ROE | 1.29% | KR#1,460/2,405 Sec#186/292 |
| ROA | 0.73% | KR#1,439/2,405 Sec#187/292 |
| Op. Margin | 3.40% | KR#1,182/2,405 Sec#136/292 |
| Revenue Growth | 7.81% | KR#1,026/2,405 Sec#118/292 |
| Earnings Growth | 305.71% | KR#162/2,405 Sec#21/292 |
| Financial Health | ||
| Debt Ratio | 77.17% | KR#1,301/2,405 Sec#159/292 |
| Total Debt | 23.73B KRW | KR#1,321/2,405 Sec#207/292 |
| FCF | 2.27B KRW | KR#1,062/2,405 Sec#125/292 |
| Cash | 2.51B KRW | KR#2,189/2,405 Sec#268/292 |
| Current Ratio | 1.72x | KR#1,014/2,405 Sec#109/292 |
| Net Debt/EBITDA | 17.24x | KR#1,345/2,405 Sec#175/292 |
| Performance | ||
| 1Y Return | -12.58% | KR#890/2,405 Sec#123/292 |
| 1M Return | -1.90% | KR#449/2,405 Sec#58/292 |
| From 52W High | -19.05% | KR#172/2,405 Sec#30/292 |
| 1Y MDD | -20.33% | KR#63/2,405 Sec#21/292 |
| Trading | ||
| Volume | 2,073 shares | KR#2,263/2,405 Sec#269/292 |
| Trading Value | 4.0M KRW | KR#2,328/2,405 Sec#280/292 |
| Foreign Own. | 1.26% | KR#1,921/2,405 Sec#230/292 |
| Per Share | ||
| EPS | 53 KRW | KR#1,496/2,405 Sec#194/292 |
| BPS | 4,097 KRW | KR#1,658/2,405 Sec#226/292 |
Company Info
동사는 1997년 농약 제조 및 판매를 목적으로 설립된 후 2020년 코스닥시장에서 상장됨. 살균, 살충, 제초제 등 작물 보호제와 비료를 농협경제지주 및 지역별 도소매상을 통해 판매하고, 다기능 살균살충제 및 친환경 작물보호제를 생산함. 최근 10년간 174품목 개발 등록과 노동력 절감 효과가 있는 합제 및 고부가가치 제품 개발에 집중하며, 세계 최초 바이러스 치료제 등록 신청 등 지속적인 연구개발을 추진하고 있음. 인바이오는 1997년에 설립되었으며 경기도 군포시에 본사를 두고 있습니다.